Research Summary
Cannabidiol (CBD) is a naturally occurring compound found in the cannabis plant. It is one of many cannabinoids present in cannabis, but unlike tetrahydrocannabinol (THC), it does not produce psychoactive effects or a feeling of being "high." CBD has gained significant attention for its potential therapeutic properties and has been studied for its effects on various health conditions. It interacts with the body's endocannabinoid system (ECS), which plays a role in regulating functions such as sleep, mood, pain sensation, and immune response. CBD is believed to have anti-inflammatory, analgesic, anxiolytic, and neuroprotective effects, among others. It is available in different forms, including oils, capsules, topicals, and edibles, and is used by individuals seeking relief from pain, anxiety, insomnia, seizures, and other health concerns. CBD's growing popularity has led to increased research and exploration of its potential benefits and limitations in the medical and wellness fields. It is important to note that CBD products vary in quality and potency, and it is advisable to consult with a healthcare professional before using CBD for any specific health condition.
According to WENKH research statistics, the global Cannabidiol (CBD) market size will reach 510.01 Million USD in 2025 and is projected to reach 1,257.49 Million USD by 2032, with a CAGR of 13.76% (2025-2032). Among them, the Asia-Pacific Cannabidiol (CBD) market is undergoing rapid changes, reaching Million USD in 2025, accounting for approximately % of the global market share. It is projected to reach Million USD by 2032.
The global Cannabidiol (CBD) market is highly competitive, with key market players including Kazmira, CW Hemp/CW Botanicals, Freedom Leaf, Green Road, Medical Marijuana, Folium Biosciences, HempLife Today, Cannavest, Pharmahemp, ENDOCA, CBD American Shaman, NuLeaf Naturals, Select Oil, Canopy Growth Corporation, K.I.N.D. Concentrates, Aphria, Emblem Cannabis Oils, Whistler, The Lab, Absolute Terps, etc. This report categorizes the competitive landscape of the global Cannabidiol (CBD) market into three tiers based on annual revenue, with the top three market players holding approximately % of the total market share.
This report provides an in-depth analysis of the global Cannabidiol (CBD) market, including market size, price trends, market status and future development prospects. It particularly focuses on the market share, product characteristics, pricing, revenue, sales volume and gross profit margin of major manufacturers in the global Cannabidiol (CBD) industry. Additionally, this report provides an in-depth analysis of the market status and future development trends of different segments of Cannabidiol (CBD) and their downstream application fields.
In terms of data coverage, this report includes extensive time-series data. Historical data spans from 2020 to 2024, providing a solid foundation for analyzing market development trends. The year 2025 is used as a base year to accurately assess the current market landscape, while forecast data extends from 2026 to 2032, using scientific analysis methods and models to offer forward-looking projections and insights into the market's future trajectory. This provides valuable reference information for industry participants and stakeholders.
The report covers regions and countries including North America, Europe, China, Asia Pacific (excluding China), Latin America, the Middle East, and Africa. It particularly focuses on the revenue and sales volume of Cannabidiol (CBD) in these regions and countries, as well as the market share of key market players in each region. The report provides an in-depth analysis of the regional distribution and future development trends of the Cannabidiol (CBD) market. By considering local policies, this report evaluates the market prospects of Cannabidiol (CBD) in each region and country, aiming to help companies gain a comprehensive understanding of the industry characteristics and development potential in different regions, optimize regional business layout, and develop precise market strategies to achieve global development goals.
This report places significant emphasis on data quality and reliability, leveraging a wide range of data sources to ensure accuracy and validity. Primary data collection is conducted through multiple channels, including in-depth interviews with senior corporate executives, industry experts, supply chain participants, and end consumers. This helps to gain insights into corporate strategic planning, industry policies, supply chain dynamics, and user experiences. Secondary data sources cover an extensive range, including authoritative government statistics, customs databases, industry related reports, third-party paid databases, investment research reports, academic studies, corporate financial statements, real-time media updates, and information from international organizations, all of which serve as a solid foundation for data verification and analysis.
Companies Covered
Kazmira
CW Hemp/CW Botanicals
Freedom Leaf
Green Road
Medical Marijuana
Folium Biosciences
HempLife Today
Cannavest
Pharmahemp
ENDOCA
CBD American Shaman
NuLeaf Naturals
Select Oil
Canopy Growth Corporation
K.I.N.D. Concentrates
Aphria
Emblem Cannabis Oils
Whistler
The Lab
Absolute Terps
Product Segment
Hemp-derived
Marijuana-derived
Product Application
Pharmaceuticals
Food
Cosmetics
Other
Chapter Scope
Chapter 1: Product Statistical Scope, Product Segmentation Types and Downstream Applications, Overall Market Size, Current Status and Development Prospects
Chapter 2: Global Cannabidiol (CBD) Industry Chain Analysis
Chapter 3: Global Cannabidiol (CBD) Industry Environment Analysis and Porter's Five Forces Analysis
Chapter 4: Analysis of the Competitive Landscape of Major Companies in the Global Cannabidiol (CBD) Market (Market Share, Product Revenue and Sales Volume Comparison, Tier Division, Corporate Expansion and M&A Trends)
Chapter 5: Analysis of Global Major Companies (Company Profiles, Product Features and Product Segment, Product Revenue, Product Sales Volume, Product Average Price, Product Gross Profit Margin and Geographical Sales Share)
Chapter 6: Global Cannabidiol (CBD) Product Segment, Downstream Application and Major Regional Market Size Analysis (Sales Volume, Revenue and Average Price)
Chapter 7: North America Cannabidiol (CBD) Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)
Chapter 8: Europe Cannabidiol (CBD) Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)
Chapter 9: China Cannabidiol (CBD) Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)
Chapter 10: Asia Pacific (excluding China) Cannabidiol (CBD) Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)
Chapter 11: Latin America Cannabidiol (CBD) Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)
Chapter 12: Middle East and Africa Cannabidiol (CBD) Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)
Chapter 13: Research Conclusion
Chapter 14: Methodology and Data Source
Purpose and Value of the Report
Market Trend Insights: Analyze industry trends, market dynamics, and future growth potential to help companies forecast changes and develop strategic plans.
Competitive Landscape Analysis: Understand key players' revenue segmentation, strategies, market share, and business models to guide competitive decisions.
Investment Decision Support: Provide feasibility analysis through market size, growth rate, demand trends, and potential risks for informed investment decisions.
Target Customer and Demand Analysis: Examine consumer behavior, purchasing preferences, and pain points to optimize products and improve market penetration.
Policy and Regulatory Insights: Interpret relevant industry policies to ensure compliance and mitigate regulatory risks.
Business Model Optimization: Offer data-driven suggestions for enhancing business models and improving profitability.